(0.50%) 5 043.50 points
(0.51%) 38 096 points
(0.95%) 15 753 points
(0.10%) $79.08
(5.43%) $2.04
(-0.04%) $2 310.10
(0.33%) $26.84
(0.90%) $963.50
(0.01%) $0.933
(-0.15%) $11.01
(0.06%) $0.799
(-1.36%) $92.00
Live Chart Being Loaded With Signals
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China...
Stats | |
---|---|
Šios dienos apimtis | 314 000 |
Vidutinė apimtis | 427 589 |
Rinkos kapitalizacija | 8.19B |
EPS | HKD0 ( 2023-10-30 ) |
Last Dividend | HKD0.342 ( 2023-06-30 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 14.97 |
ATR14 | HKD0.00500 (0.04%) |
Tūris Koreliacija
Beijing Chunlizhengda Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Beijing Chunlizhengda Koreliacija - Valiuta/Žaliavos
Beijing Chunlizhengda Finansinės ataskaitos
Annual | 2023 |
Pajamos: | HKD1.21B |
Bruto pelnas: | HKD855.18M (70.76 %) |
EPS: | HKD0.720 |
FY | 2023 |
Pajamos: | HKD1.21B |
Bruto pelnas: | HKD855.18M (70.76 %) |
EPS: | HKD0.720 |
FY | 2022 |
Pajamos: | HKD1.20B |
Bruto pelnas: | HKD913.53M (76.03 %) |
EPS: | HKD0.800 |
FY | 2021 |
Pajamos: | HKD1.11B |
Bruto pelnas: | HKD854.54M (77.11 %) |
EPS: | HKD0.930 |
Financial Reports:
No articles found.
Beijing Chunlizhengda Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.342 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0223 | 2015-06-18 |
Last Dividend | HKD0.342 | 2023-06-30 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 10 | -- |
Total Paid Out | HKD0.833 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.67 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.69 | |
Div. Directional Score | 6.92 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9600.HK | No Dividend Player | 2023-06-14 | Insufficient data to determine frequency | 0 | 0.00% | |
2111.HK | Ex Dividend Knight | 2023-09-13 | Annually | 0 | 0.00% | |
1117.HK | Ex Dividend Junior | 2023-06-08 | Sporadic | 0 | 0.00% | |
0189.HK | Ex Dividend Junior | 2023-06-14 | Annually | 0 | 0.00% | |
3813.HK | Ex Dividend Junior | 2023-09-12 | Sporadic | 0 | 0.00% | |
1705.HK | Ex Dividend Knight | 2023-09-25 | Annually | 0 | 0.00% | |
0732.HK | Ex Dividend Knight | 2023-11-10 | Annually | 0 | 0.00% | |
2285.HK | Ex Dividend Junior | 2023-06-06 | Annually | 0 | 0.00% | |
1271.HK | Ex Dividend Junior | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
0327.HK | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.230 | 1.500 | 5.40 | 8.10 | [0 - 0.5] |
returnOnAssetsTTM | 0.0762 | 1.200 | 7.46 | 8.95 | [0 - 0.3] |
returnOnEquityTTM | 0.0996 | 1.500 | -0.00422 | -0.00633 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 4.44 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.75 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.871 | 1.500 | 0.714 | 1.071 | [0.2 - 2] |
debtRatioTTM | 0.000146 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 29 782 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.310 | 2.00 | 9.56 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.225 | 2.00 | 9.39 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.000185 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.708 | 1.000 | 1.540 | 1.540 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.217 | 1.000 | 7.66 | 7.66 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 962.70 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.331 | 0.800 | -1.126 | -0.901 | [0.5 - 2] |
Total Score | 10.14 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.71 | 1.000 | 8.62 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0996 | 2.50 | -0.00271 | -0.00633 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.225 | 2.00 | 9.59 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.27 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.310 | 2.00 | 9.56 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.137 | 1.500 | -2.42 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.423 | 1.000 | 1.914 | 0 | [0.1 - 0.5] |
Total Score | 3.69 |
Beijing Chunlizhengda
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. The company primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. It also exports its products to various countries. The company was incorporated in 1998 and is headquartered in Beijing, China.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.